| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.31B | 139.66B | 133.70B | 118.51B | 105.54B | 112.91B |
| Gross Profit | 46.60B | 52.14B | 46.45B | 39.47B | 34.86B | 38.76B |
| EBITDA | 18.05B | 20.97B | 18.66B | 14.77B | 12.68B | 15.51B |
| Net Income | 10.63B | 13.65B | 11.10B | 8.57B | 7.02B | 9.35B |
Balance Sheet | ||||||
| Total Assets | 154.63B | 181.81B | 168.28B | 158.67B | 151.94B | 149.00B |
| Cash, Cash Equivalents and Short-Term Investments | 55.17B | 39.54B | 47.52B | 46.61B | 48.96B | 48.75B |
| Total Debt | 0.00 | 0.00 | 150.00M | 0.00 | 0.00 | 13.00M |
| Total Liabilities | 27.48B | 42.82B | 38.25B | 33.51B | 35.30B | 37.10B |
| Stockholders Equity | 126.04B | 138.55B | 128.84B | 123.64B | 114.94B | 110.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.32B | 9.31B | 793.00M | 2.17B | -635.00M |
| Operating Cash Flow | 0.00 | 14.55B | 11.55B | 3.28B | 5.19B | 3.56B |
| Investing Cash Flow | 0.00 | -15.87B | -7.09B | -2.66B | -2.61B | -4.87B |
| Financing Cash Flow | 0.00 | -6.79B | -7.47B | -2.85B | -2.47B | -2.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥106.76B | 19.73 | ― | 0.82% | 8.60% | 28.39% | |
82 Outperform | ¥171.32B | 16.73 | ― | 1.39% | 12.59% | 26.31% | |
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
70 Outperform | ¥53.85B | 14.18 | ― | 3.69% | 9.40% | 34.69% | |
65 Neutral | ¥573.58B | 16.45 | ― | 2.14% | 8.18% | 23.30% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |